Click on image to view larger version.

Figure 1 Nine-month clinical outcome for insulin-treated diabetic patients enrolled in the Strategic Transcatheter Evaluation of New Therapies (STENT) trial. Completed nine-month follow-up: 5,566, 93.7%. p = NS for all. Blue bars = sirolimus-eluting stent; yellow bars = paclitaxel-eluting stent. MACE = major adverse cardiac events; MI = myocardial infarction; TVR = target vessel revascularization.